Search Results - "Schatzberg"

Refine Results
  1. 1

    HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition by Keller, J, Gomez, R, Williams, G, Lembke, A, Lazzeroni, L, Murphy, G M, Schatzberg, A F

    Published in Molecular psychiatry (01-04-2017)
    “…The hypothalamic–pituitary–adrenal (HPA) axis has been implicated in the pathophysiology of a variety of mood and cognitive disorders. Neuroendocrine studies…”
    Get full text
    Journal Article
  2. 2

    Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression by Bernard, R, Kerman, I A, Thompson, R C, Jones, E G, Bunney, W E, Barchas, J D, Schatzberg, A F, Myers, R M, Akil, H, Watson, S J

    Published in Molecular psychiatry (01-06-2011)
    “…Several studies have proposed that brain glutamate signaling abnormalities and glial pathology have a role in the etiology of major depressive disorder (MDD)…”
    Get full text
    Journal Article
  3. 3

    Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story? by Schatzberg, Alan F.

    Published in The American journal of psychiatry (01-07-2022)
    “…Schatzberg discusses the report from Tabuteau et al which indicates that the combination of 90 mg of dextromethorphan and 210 mg of bupropion (AXS-05) is…”
    Get full text
    Journal Article
  4. 4

    Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? by Sanacora, Gerard, Schatzberg, Alan F

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2015)
    “…Large 'real world' studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Historiography: Why Should Historians Pay More Attention to Philosophy of Technology? by Schatzberg, Eric

    Published in Technology and culture (01-07-2024)
    “…The Oxford Handbook of Philosophy of Technology marks the maturity of the philosophy of technology, which has lagged behind the history of technology as a…”
    Get more information
    Journal Article
  7. 7

    Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder by Bunney, B G, Li, J Z, Walsh, D M, Stein, R, Vawter, M P, Cartagena, P, Barchas, J D, Schatzberg, A F, Myers, R M, Watson, S J, Akil, H, Bunney, W E

    Published in Molecular psychiatry (01-02-2015)
    “…Conventional antidepressants require 2–8 weeks for a full clinical response. In contrast, two rapidly acting antidepressant interventions, low-dose ketamine…”
    Get full text
    Journal Article
  8. 8

    HPA axis genetic variation, cortisol and psychosis in major depression by Schatzberg, A F, Keller, J, Tennakoon, L, Lembke, A, Williams, G, Kraemer, F B, Sarginson, J E, Lazzeroni, L C, Murphy, G M

    Published in Molecular psychiatry (01-02-2014)
    “…Genetic variation underlying hypothalamic pituitary adrenal (HPA) axis overactivity in healthy controls (HCs) and patients with severe forms of major…”
    Get full text
    Journal Article
  9. 9

    A Word to the Wise About Intranasal Esketamine by Schatzberg, Alan F

    Published in The American journal of psychiatry (01-06-2019)
    “…Schatzberg discusses the study of Popova et al regarding intranasal esketamine, the putatively more effective enantiomer of ketamine. This pivotal phase 3…”
    Get full text
    Journal Article
  10. 10

    HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition by Cherian, Kirsten, Schatzberg, Alan F., Keller, Jennifer

    Published in Schizophrenia research (01-11-2019)
    “…The Hypothalamic Pituitary Adrenal (HPA) axis has been implicated in the pathophysiology of a variety of mood and cognitive disorders. Neuroendocrine studies…”
    Get full text
    Journal Article
  11. 11

    A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders by Sanacora, Gerard, Frye, Mark A, McDonald, William, Mathew, Sanjay J, Turner, Mason S, Schatzberg, Alan F, Summergrad, Paul, Nemeroff, Charles B

    Published in JAMA psychiatry (Chicago, Ill.) (01-04-2017)
    “…Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety…”
    Get more information
    Journal Article
  12. 12

    An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression by Schatzberg, Alan F.

    Published in The American journal of psychiatry (01-12-2022)
    “…Schatzberg discusses the report by Price et al that automated self-associated training (ASAT) was statistically better than sham treatment in maintaining the…”
    Get full text
    Journal Article
  13. 13

    Common Abnormalities and Disorder-Specific Compensation During Implicit Regulation of Emotional Processing in Generalized Anxiety and Major Depressive Disorders by Etkin, Amit, Schatzberg, Alan F.

    Published in The American journal of psychiatry (01-09-2011)
    “…Processing deficits were observed in the ventral anterior cingulate and amygdala of patients with major depression and/or generalized anxiety disorder, but…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism by Williams, Nolan R, Heifets, Boris D, Blasey, Christine, Sudheimer, Keith, Pannu, Jaspreet, Pankow, Heather, Hawkins, Jessica, Birnbaum, Justin, Lyons, David M, Rodriguez, Carolyn I, Schatzberg, Alan F

    Published in American Journal of Psychiatry (01-12-2018)
    “…Objective:In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine…”
    Get full text
    Journal Article
  16. 16

    Some Comments on Psychedelic Research by Schatzberg, Alan F

    Published in The American journal of psychiatry (01-05-2020)
    “…Schatzberg reflects on the effort of the American Psychiatric Association's Council of Research to review studies on psychedelics and psychedelic-assisted…”
    Get full text
    Journal Article
  17. 17

    Can Target Engagement Studies Miss Their Targets and Mislead Drug Development? by Schatzberg, Alan F

    Published in The American journal of psychiatry (01-05-2021)
    “…The study by Costi ct aL (1), in this issue of the Journal, reports exciting data that a potassium anion channel modulator, ezogabinc, has a significant effect…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging by Oathes, Desmond J, Patenaude, Brian, Schatzberg, Alan F, Etkin, Amit

    Published in Biological psychiatry (1969) (15-02-2015)
    “…Abstract Background There is increasing interest in using neurobiological measures to inform psychiatric nosology. It is unclear at the present time whether…”
    Get full text
    Journal Article